Voriconazole is a broad spectrum, triazole antifungal agent and is indicated as follows: Treatment of invasive aspergillosis; Treatment of candidemia in non-neutropenic patients; Treatment of serious invasive Candida infections (including C. krusei); Treatment of esophageal candidiasis; Treatment of serious fungal infections caused by Scedosporium apiospermum (asexual form of Pseudallescheria boydii) and Fusarium spp. including Fusarium solani, in patients intolerant of, or refractory to, other therapy; Prevention of breakthrough of fungal infections in febrile high-risk patients (allogeneic bone marrow transplants, relapsed leukemia patients); Prophylaxis in patients who are at high risk of developing invasive fungal infections, such as hematopoietic stem cell transplant (HSCT) recipients.
Sign Out
